|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.630 USD | +0.77% |
|
+5.20% | -89.58% |
| 25/06 | Jaguar Health to Seek European Regulatory Approval for Dog Diarrhea Treatment | MT |
| 11/06 | Jaguar Health Establishes First Site for Canalevia-CA1 Field Study | MT |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| JAGUAR HEALTH, INC. | Other Pharmaceuticals | +0.77% | +5.20% | -89.58% | -97.36% | -100.00% | 34.57L |  | | |
- Stock Market
- Equities
- JAGX Stock
- Charts Jaguar Health, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition